SAM
Smartleaf Asset Management Portfolio holdings
AUM
$1.13B
1-Year Return
18.27%
This Quarter Return
-1.36%
1 Year Return
+18.27%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.04B
AUM Growth
+$55.5M
(+5.7%)
Cap. Flow
+$92M
Cap. Flow
% of AUM
8.88%
Top 10 Holdings %
Top 10 Hldgs %
18.73%
Holding
3,051
New
134
Increased
1,122
Reduced
1,281
Closed
187
Top Buys
| 1 |
Capital Group US Multi-Sector Income ETF
CGMS
|
$5.67M |
| 2 |
iShares MBS ETF
MBB
|
$5.6M |
| 3 |
Capital Group Dividend Growers ETF
CGDG
|
$5.48M |
| 4 |
WisdomTree US Value Fund
WTV
|
$3.76M |
| 5 |
Vanguard Total Bond Market
BND
|
$3.15M |
Top Sells
Sector Composition
| 1 | Technology | 16.57% |
| 2 | Financials | 9.55% |
| 3 | Healthcare | 7.05% |
| 4 | Consumer Discretionary | 5.92% |
| 5 | Industrials | 4.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Vanguard Mid-Cap ETF
VO
$87B
| $1.36M | 0.13% |
5,293
+947
| +22% | +$243K |
|
177
Altria Group
MO
$111B
| $1.35M | 0.13% |
23,176
-912
| -4% | -$53K |
|
178
Palantir
PLTR
$365B
| $1.34M | 0.13% |
15,581
+2,739
| +21% | +$235K |
|
179
Principal Spectrum Preferred Securities Active ETF
PREF
$1.29B
| $1.32M | 0.13% |
70,734
+15,625
| +28% | +$293K |
|
180
Novartis
NVS
$251B
| $1.3M | 0.13% |
11,538
+1,421
| +14% | +$160K |
|
181
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $1.3M | 0.13% |
15,710
+1,919
| +14% | +$159K |
|
182
Ameriprise Financial
AMP
$46.2B
| $1.28M | 0.12% |
2,650
+69
| +3% | +$33.3K |
|
183
Enbridge
ENB
$105B
| $1.27M | 0.12% |
28,552
+24,778
| +657% | +$1.1M |
|
184
Shell
SHEL
$207B
| $1.26M | 0.12% |
17,388
+3,941
| +29% | +$287K |
|
185
Invesco Taxable Municipal Bond ETF
BAB
$915M
| $1.26M | 0.12% |
47,499
-30,277
| -39% | -$804K |
|
186
Progressive
PGR
$143B
| $1.23M | 0.12% |
4,423
+56
| +1% | +$15.6K |
|
187
Colgate-Palmolive
CL
$68.3B
| $1.23M | 0.12% |
13,281
-19
| -0.1% | -$1.76K |
|
188
iShares US Financials ETF
IYF
$4B
| $1.23M | 0.12% |
11,026
+10,869
| +6,923% | +$1.21M |
|
189
iShares Core S&P Mid-Cap ETF
IJH
$101B
| $1.23M | 0.12% |
21,155
+1,462
| +7% | +$85.1K |
|
190
Charles Schwab
SCHW
$167B
| $1.23M | 0.12% |
15,773
+1,193
| +8% | +$92.8K |
|
191
Dimensional Core Fixed Income ETF
DFCF
$7.52B
| $1.22M | 0.12% |
29,055
+341
| +1% | +$14.3K |
|
192
SPDR S&P 1500 Value Tilt ETF
VLU
$527M
| $1.22M | 0.12% |
6,695
+1,840
| +38% | +$335K |
|
193
Technology Select Sector SPDR Fund
XLK
$83.9B
| $1.21M | 0.12% |
5,885
-6,402
| -52% | -$1.32M |
|
194
Gilead Sciences
GILD
$143B
| $1.21M | 0.12% |
10,819
+958
| +10% | +$107K |
|
195
AstraZeneca
AZN
$253B
| $1.2M | 0.12% |
16,309
+1,986
| +14% | +$147K |
|
196
SPDR MSCI ACWI Climate Paris Aligned ETF
NZAC
$176M
| $1.2M | 0.12% |
33,825
-9,702
| -22% | -$343K |
|
197
Cigna
CI
$81.5B
| $1.19M | 0.12% |
3,672
+1,363
| +59% | +$443K |
|
198
Vanguard Mid-Cap Growth ETF
VOT
$17.5B
| $1.19M | 0.12% |
4,885
+255
| +6% | +$62.2K |
|
199
CBRE Group
CBRE
$48.8B
| $1.19M | 0.11% |
9,163
+633
| +7% | +$82K |
|
200
Novo Nordisk
NVO
$244B
| $1.19M | 0.11% |
17,102
-686
| -4% | -$47.5K |
|